Results 181 to 190 of about 21,353 (254)

Real-world evaluation of interstitial lung disease/pneumonitis in patients treated with trastuzumab deruxtecan for HER2-positive advanced or recurrent gastric cancer: a postmarketing surveillance study in Japan. [PDF]

ESMO Open
Kawakami H, Uchino K, Hashimoto W, Muro K.   +3 more
europepmc   +1 more source

Getting There First With the Best: The Need to Shorten the Prescription Drug Approval Process [PDF]

, 2011
Kassel, Mark A.
core   +1 more source

Specificity of Food and Drug Administration postmarketing requirements and associations with timely submissions and regulatory decisions for oncology accelerated approvals, 2011-2023: a cross-sectional analysis. [PDF]

BMJ Oncol
Kurian M, Ferrell WJ, Ulloa Perez E, Hubbard R, Joffe S, Mamtani R, Parikh RB, Lynch HF.   +7 more
europepmc   +1 more source

Lack of Placental Transfer of Certolizumab Pegol During Pregnancy: Results from CRIB, a Prospective, Postmarketing, Multicenter, Pharmacokinetic Study

, 2017
Alexa B. Kimball, Xavier Mariette, Bincy Abraham, Ann D. Flynn, Frauke Förger, Anna Moltó, R.M. Flipo, Astrid van Tubergen, Laura Shaughnessy, Jeff Simpson, Marie Teil, Eric Helmer, Maggie Wang, Eliza Chakravarty   +13 more
openalex   +1 more source

Pragmatic implementation of intravascular lithotripsy in Japan based on the guidelines for proper use. [PDF]

Cardiovasc Interv Ther
Shiba T, Nakamura M, Kozuma K, Sugano T, Aizawa K, Yabana N, Ishii K.   +6 more
europepmc   +1 more source

Flexibility over rigor: stakeholder acceptance of the limitations of confirmatory studies following accelerated approval. [PDF]

Health Aff Sch
Fernandez Lynch H, Lee S, Herder M, Ross JS, Ramachandran R.   +4 more
europepmc   +1 more source

Cumulative review of cardiac failure with acalabrutinib in the treatment of chronic lymphocytic leukemia using data from clinical trials and postmarketing experience. [PDF]

Hemasphere
Ghia P, Bajwa N, Corry AJ, Jannuru S, Kreuzbauer G, Pareek M.   +5 more
europepmc   +1 more source

MGB3 Postmarketing Outcomes Studies: Benefits And Risks

, 1998
FB Garfield, JJ Caro
openalex   +1 more source

Artificial Intelligence in Clinical and Translational Science: From Bench Insights to Bedside Impact. [PDF]

Clin Transl Sci
Shahin MH, Liu Q.
europepmc   +1 more source

Innovative Use of Existing Public and Private Data Sources for Postmarketing Surveillance of Central Line-Associated Bloodstream Infections Associated With Intravenous Needleless Connectors

, 2016
Ying P. Tabak, Richard S. Johannes, Xiaowu Sun, Cynthia T. Crosby, William R. Jarvis   +4 more
openalex   +1 more source